SG Americas Securities LLC raised its position in shares of Relx PLC (NYSE:RELX) by 95.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 120,651 shares of the technology company’s stock after purchasing an additional 59,075 shares during the quarter. SG Americas Securities LLC’s holdings in Relx were worth $2,945,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Financial Gravity Wealth Inc. purchased a new stake in Relx during the 1st quarter valued at about $30,000. Icon Wealth Partners LLC purchased a new stake in Relx during the 1st quarter valued at about $32,000. Zions Bancorporation N.A. purchased a new stake in Relx during the 1st quarter valued at about $42,000. Parallel Advisors LLC grew its stake in Relx by 1,003.9% during the 1st quarter. Parallel Advisors LLC now owns 2,826 shares of the technology company’s stock valued at $61,000 after purchasing an additional 2,570 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. grew its stake in Relx by 27.0% during the 2nd quarter. Shine Investment Advisory Services Inc. now owns 3,487 shares of the technology company’s stock valued at $85,000 after purchasing an additional 741 shares during the last quarter. Institutional investors and hedge funds own 5.21% of the company’s stock.
Relx stock opened at $23.58 on Wednesday. The company has a current ratio of 0.45, a quick ratio of 0.40 and a debt-to-equity ratio of 2.58. The company’s 50-day moving average price is $24.17. The stock has a market cap of $24.77 billion, a P/E ratio of 20.87, a PEG ratio of 3.11 and a beta of 0.47. Relx PLC has a fifty-two week low of $19.23 and a fifty-two week high of $24.99.
Separately, Zacks Investment Research upgraded Relx from a “hold” rating to a “buy” rating and set a $27.00 price target on the stock in a research note on Wednesday, July 31st.
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
Featured Article: Calculate Your Return on Investment (ROI)
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx PLC (NYSE:RELX).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.